Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Stock-based Compensation (Tables)

v3.24.1.1.u2
Note 13 - Stock-based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Notes Tables  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
   

Awards Reserved for Issuance

   

Awards Exercised

   

Awards Outstanding

   

Awards Available for Grant

 

2016 Equity Incentive Plan

    2,000,000       —       2,489       1,997,511  

2018 Equity Incentive Plan

    43,976,425       40,221       245,871       43,690,333  

2019 Equity Incentive Plan

    55,000,000       349       119,992       54,879,659  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
   

(in thousands, except for shares / options)

 
   

For the Three Months Ended

 
   

March 31, 2024

   

March 31, 2023

 
   

Number of

           

Number of

         
   

Shares or

   

Stock-Based

   

Shares or

   

Stock-Based

 
   

Options

   

Compensation

   

Options

   

Compensation

 

Type of Award

 

Granted

   

Expense

   

Granted

   

Expense

 

Stock Options

    —     $ 110       —     $ 99  
                                 

Stock Grants:

                               

Employees (Common Stock)

    —       —       —       —  

Directors (Common Stock)

    —       —       —       —  

Non–Employee Consultants (Common Stock)

    —       —       161,812       356  

Total Stock–Based Compensation Expense

          $ 110             $ 455  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
                   

Weighted-

   

Aggregate

 
                   

Average

   

Intrinsic

 
           

Weighted-

   

Remaining

   

Value of

 
   

Number of

   

Average Exercise

   

Contractual

   

In-the-Money

 
   

Shares

   

Price Per Share

   

Life (in years)

   

Options

 

Options Outstanding as of January 1, 2024

    369,301     $ 13.00                  

Options Outstanding as of March 31, 2024

    369,301     $ 12.58       8.0 years     $ —  

Options Exercisable as of March 31, 2024

    360,333     $ 12.57       8.1 years     $ —